157
Views
19
CrossRef citations to date
0
Altmetric
Effect of a COX-2 Inhibitor on an Arthritis Model

Effect of selective COX-2 inhibitor, celecoxib on adjuvant-induced arthritis model in irradiated rats

, , &
Pages 1079-1087 | Received 16 Aug 2009, Accepted 14 Jun 2010, Published online: 10 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (18)

Aurora Leontina Lombardi, Lucia Manfredi & David Conversi. (2023) How does IL-6 change after combined treatment in MDD patients? A systematic review. Brain, Behavior, & Immunity - Health 27, pages 100579.
Crossref
Sherien A. Abdelhady, Mennatallah A. Ali, Tamer A. Al-Shafie, Ebtsam M. Abdelmawgoud, Dalia M. Yacout & Mahmoud M. El-Mas. (2021) Montelukast potentiates the antiinflammatory effect of NSAIDs in the rat paw formalin model and simultaneously minimizes the risk of gastric damage. Inflammation Research 70:9, pages 981-992.
Crossref
Joan Anak Blin, Razana Mohd Ali, Armania Nurdin & Roslida Abd Hamid. (2021) Quinone-rich fraction of Ardisia crispa (Thunb.) A. DC roots alters angiogenic cascade in collagen-induced arthritis. Inflammopharmacology 29:3, pages 771-788.
Crossref
Rasoul Azmoonfar, Peyman Amini, Hana Saffar, Elahe Motevaseli, Ehsan Khodamoradi, Dheyauldeen Shabeeb, Ahmed Eleojo Musa & Masoud Najafi. (2020) Celecoxib A Selective COX-2 Inhibitor Mitigates Fibrosis but not Pneumonitis Following Lung Irradiation: A Histopathological Study. Current Drug Therapy 15:4, pages 351-357.
Crossref
Bagher Farhood, Milad Ashrafizadeh, Ehsan khodamoradi, Mojtaba Hoseini-Ghahfarokhi, Shima Afrashi, Ahmed Eleojo Musa & Masoud Najafi. (2020) Targeting of cellular redox metabolism for mitigation of radiation injury. Life Sciences 250, pages 117570.
Crossref
Keywan Mortezaee, Masoud Najafi, Bagher Farhood, Amirhossein Ahmadi, Dheyauldeen Shabeeb & Ahmed E. Musa. (2019) NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity. Journal of Cellular Physiology 234:10, pages 17187-17204.
Crossref
Bagher Farhood, Nasser Hashemi Goradel, Keywan Mortezaee, Neda Khanlarkhani, Masoud Najafi & Amirhossein Sahebkar. (2018) Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment. Journal of Cellular Physiology 234:5, pages 5613-5627.
Crossref
M.A. El-GhazalyN. FadelE. RashedA. El-BatalS.A. Kenawy. (2017) Anti-inflammatory effect of selenium nanoparticles on the inflammation induced in irradiated rats. Canadian Journal of Physiology and Pharmacology 95:2, pages 101-110.
Crossref
Markus Laube, Torsten Kniess & Jens Pietzsch. (2016) Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review. Antioxidants 5:2, pages 14.
Crossref
Payam Mohammadinejad, Pantea Arya, Mohsen Esfandbod, Ahmad Kaviani, Masoome Najafi, Ladan Kashani, Atefeh Zeinoddini, Seyed Amirhossein Emami & Shahin Akhondzadeh. (2015) Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients. Annals of Pharmacotherapy 49:9, pages 953-961.
Crossref
R. M. El-Sayed, Y. M. Moustafa & M. F. El-Azab. (2014) Evening primrose oil and celecoxib inhibited pathological angiogenesis, inflammation, and oxidative stress in adjuvant-induced arthritis: novel role of angiopoietin-1. Inflammopharmacology 22:5, pages 305-317.
Crossref
XIAOYU CHEN, JINSENG LU, MEI AN, ZHONGFEI MA, HEXIANG ZONG & JUN YANG. (2014) Anti-inflammatory effect of resveratrol on adjuvant arthritis rats with abnormal immunological function via the reduction of cyclooxygenase-2 and prostaglandin E2. Molecular Medicine Reports 9:6, pages 2592-2598.
Crossref
Da-Eun Nam, Ok Kyung Kim, Tae Jin Shim, Ji Hoon Kim & Jeongmin Lee. (2014) Effect of Boswellia serrata Extracts on Degenerative Osteoarthritis in vitro and in vivo Models. Journal of the Korean Society of Food Science and Nutrition 43:5, pages 631-640.
Crossref
Ronise M. Santiago, Janaína Barbiero, Bruno J. Martynhak, Suelen L. Boschen, Luisa M. da Silva, Maria F. P. Werner, Claudio Da Cunha, Roberto Andreatini, Marcelo M. S. Lima & Maria A. B. F. Vital. (2014) Antidepressant-like effect of celecoxib piroxicam in rat models of depression. Journal of Neural Transmission.
Crossref
Tobias A. Mattei, Carlos R. Goulart & Todd D. McCall. (2012) Pathophysiology of regression of synovial cysts of the lumbar spine: The ‘anti-inflammatory hypothesis’. Medical Hypotheses 79:6, pages 813-818.
Crossref
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi & Shahin Akhondzadeh. (2012) Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study. Journal of Affective Disorders 141:2-3, pages 308-314.
Crossref
Cheuk-Lun Liu, Ling Cheng, Chun-Hay Ko, Chun-Wai Wong, Wai-Hing Cheng, David Wing-Shing Cheung, Ping-Chung Leung, Kwok-Pui Fung & Clara Bik-San Lau. (2012) Bioassay-guided isolation of anti-inflammatory components from the root of Rehmannia glutinosa and its underlying mechanism via inhibition of iNOS pathway. Journal of Ethnopharmacology 143:3, pages 867-875.
Crossref
Manon C Zweers, Tineke N de Boer, Joël van Roon, Johannes WJ Bijlsma, Floris PJG Lafeber & Simon C Mastbergen. (2011) Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis. Arthritis Research & Therapy 13:5, pages 239.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.